Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hayato Tada

Showing results (71-80 of 306) with videos related to

Pageof 31
Sort By:
Internal Medicine (Tokyo, Japan)|February 23, 2026
Trends and Factors Associated with LDL-C Treatment Target Attainment Rates among Patients with Secondary Prevention Setting of Atherosclerotic Cardiovascular Disease: Assessments from Japanese Health Checkup DataAtsushi Furukawa, Hayato Tada, Kenji Sakata, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 14, 2011
[Invasive diagnostic imaging of coronary atherosclerosis]Tadatsugu Gamou, Masaaki Kawashiri, Hayato Tada, et al.
Annals of Internal Medicine|October 20, 2017
Lipoprotein Apheresis for SitosterolemiaNagahiko Sakuma, Hayato Tada, Hiroshi Mabuchi, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 16, 2020
Machine learning-based risk model using <sup>123</sup>I-metaiodobenzylguanidine to differentially predict modes of cardiac death in heart failureKenichi Nakajima, Tomoaki Nakata, Takahiro Doi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 6, 2022
Clinical and genetic features of sitosterolemia in JapanHayato Tada, Nobuko Kojima, Kan Yamagami, et al.
Lipids in Health and Disease|January 6, 2020
Beneficial effect of ezetimibe-atorvastatin combination therapy in patients with a mutation in ABCG5 or ABCG8 geneHayato Tada, Hirofumi Okada, Akihiro Nomura, et al.
Journal of Cardiology|September 23, 2021
Human genetics and its impact on cardiovascular diseaseHayato Tada, Noboru Fujino, Kenshi Hayashi, et al.
Journal of Atherosclerosis and Thrombosis|May 1, 2020
Low-Density Lipoprotein Cholesterol Level cannot be too Low: Considerations from Clinical Trials, Human Genetics, and BiologyHayato Tada, Soichiro Usui, Kenji Sakata, et al.
Journal of Atherosclerosis and Thrombosis|September 9, 2015
Common and Rare Variant Association Study for Plasma Lipids and Coronary Artery DiseaseHayato Tada, Masa-aki Kawashiri, Tetsuo Konno, et al.
Journal of Atherosclerosis and Thrombosis|November 24, 2020
Challenges of Precision Medicine for Atherosclerotic Cardiovascular Disease Based on Human Genome InformationHayato Tada, Soichiro Usui, Kenji Sakata, et al.
Pageof 31

Showing results (71-80 of 306) with videos related to

Sort By:
Pageof 31
Internal Medicine (Tokyo, Japan)|February 23, 2026
Trends and Factors Associated with LDL-C Treatment Target Attainment Rates among Patients with Secondary Prevention Setting of Atherosclerotic Cardiovascular Disease: Assessments from Japanese Health Checkup DataAtsushi Furukawa, Hayato Tada, Kenji Sakata, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 14, 2011
[Invasive diagnostic imaging of coronary atherosclerosis]Tadatsugu Gamou, Masaaki Kawashiri, Hayato Tada, et al.
Annals of Internal Medicine|October 20, 2017
Lipoprotein Apheresis for SitosterolemiaNagahiko Sakuma, Hayato Tada, Hiroshi Mabuchi, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 16, 2020
Machine learning-based risk model using <sup>123</sup>I-metaiodobenzylguanidine to differentially predict modes of cardiac death in heart failureKenichi Nakajima, Tomoaki Nakata, Takahiro Doi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 6, 2022
Clinical and genetic features of sitosterolemia in JapanHayato Tada, Nobuko Kojima, Kan Yamagami, et al.
Lipids in Health and Disease|January 6, 2020
Beneficial effect of ezetimibe-atorvastatin combination therapy in patients with a mutation in ABCG5 or ABCG8 geneHayato Tada, Hirofumi Okada, Akihiro Nomura, et al.
Journal of Cardiology|September 23, 2021
Human genetics and its impact on cardiovascular diseaseHayato Tada, Noboru Fujino, Kenshi Hayashi, et al.
Journal of Atherosclerosis and Thrombosis|May 1, 2020
Low-Density Lipoprotein Cholesterol Level cannot be too Low: Considerations from Clinical Trials, Human Genetics, and BiologyHayato Tada, Soichiro Usui, Kenji Sakata, et al.
Journal of Atherosclerosis and Thrombosis|September 9, 2015
Common and Rare Variant Association Study for Plasma Lipids and Coronary Artery DiseaseHayato Tada, Masa-aki Kawashiri, Tetsuo Konno, et al.
Journal of Atherosclerosis and Thrombosis|November 24, 2020
Challenges of Precision Medicine for Atherosclerotic Cardiovascular Disease Based on Human Genome InformationHayato Tada, Soichiro Usui, Kenji Sakata, et al.
Pageof 31